Improved chemotherapy modeling with RAG-based immune deficient mice
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Improved chemotherapy modeling with RAG-based immune deficient mice
Authors
Keywords
-
Journal
PLoS One
Volume 14, Issue 11, Pages e0225532
Publisher
Public Library of Science (PLoS)
Online
2019-11-21
DOI
10.1371/journal.pone.0225532
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Abemaciclib, a Selective CDK4/6 Inhibitor, Enhances the Radiosensitivity of Non–Small Cell Lung CancerIn VitroandIn Vivo
- (2018) Sarwat Naz et al. CLINICAL CANCER RESEARCH
- Humanized mice in studying efficacy and mechanisms of PD-1-targeted cancer immunotherapy
- (2018) Minan Wang et al. FASEB JOURNAL
- Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells
- (2018) Maria Krevvata et al. HAEMATOLOGICA
- CPX-351 (cytarabine and daunorubicin) Liposome for Injection Versus Conventional Cytarabine Plus Daunorubicin in Older Patients With Newly Diagnosed Secondary Acute Myeloid Leukemia
- (2018) Jeffrey E. Lancet et al. JOURNAL OF CLINICAL ONCOLOGY
- Daunorubicin during delayed intensification decreases the incidence of infectious complications – a randomized comparison in trial CoALL 08-09
- (2018) Franziska Schramm et al. LEUKEMIA & LYMPHOMA
- Cytokines increase engraftment of human acute myeloid leukemia cells in immunocompromised mice but not engraftment of human myelodysplastic syndrome cells
- (2018) Maria Krevvata et al. HAEMATOLOGICA
- Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia
- (2018) Cathy C Zhang et al. NEOPLASIA
- Comparative utility of NRG and NRGS mice for the study of normal hematopoiesis, leukemogenesis, and therapeutic response
- (2018) Aditya Barve et al. EXPERIMENTAL HEMATOLOGY
- Improved multilineage human hematopoietic reconstitution and function in NSGS mice
- (2018) Mark Wunderlich et al. PLoS One
- Enhancing venetoclax activity in acute myeloid leukemia by co-targeting MCL1
- (2017) T-C Teh et al. LEUKEMIA
- Efficacy and safety of native versus pegylated Escherichia coli asparaginase for treatment of adults with high-risk, Philadelphia chromosome-negative acute lymphoblastic leukemia
- (2017) Josep-Maria Ribera et al. LEUKEMIA & LYMPHOMA
- Novel combinations of PI3K-mTOR inhibitors with dacomitinib or chemotherapy in PTEN-deficient patient-derived tumor xenografts
- (2017) Irene Brana et al. Oncotarget
- Valproic Acid Sensitizes Hepatocellular Carcinoma Cells to Proton Therapy by Suppressing NRF2 Activation
- (2017) Jeong Il Yu et al. Scientific Reports
- The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice
- (2016) Elizabeth C. Townsend et al. CANCER CELL
- Discovery of DS-5272 as a promising candidate: A potent and orally active p53–MDM2 interaction inhibitor
- (2015) Masaki Miyazaki et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation
- (2015) J. Sperlazza et al. BLOOD
- Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice
- (2015) E. M. Lee et al. HAEMATOLOGICA
- Equivalence Ratio for Daunorubicin to Doxorubicin in Relation to Late Heart Failure in Survivors of Childhood Cancer
- (2015) Elizabeth A.M. Feijen et al. JOURNAL OF CLINICAL ONCOLOGY
- Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
- (2015) Andrew E Place et al. LANCET ONCOLOGY
- Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin
- (2015) Zuzanna Baranski et al. Oncotarget
- MLL-Rearranged Acute Lymphoblastic Leukemias Activate BCL-2 through H3K79 Methylation and Are Sensitive to the BCL-2-Specific Antagonist ABT-199
- (2015) Juliana M. Benito et al. Cell Reports
- Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice
- (2015) E. M. Lee et al. HAEMATOLOGICA
- Residual Disease in a Novel Xenograft Model of RUNX1-Mutated, Cytogenetically Normal Acute Myeloid Leukemia
- (2015) Umayal Sivagnanalingam et al. PLoS One
- OKT3 prevents xenogeneic GVHD and allows reliable xenograft initiation from unfractionated human hematopoietic tissues
- (2014) M. Wunderlich et al. BLOOD
- Telomerase Inhibition Effectively Targets Mouse and Human AML Stem Cells and Delays Relapse following Chemotherapy
- (2014) Claudia Bruedigam et al. Cell Stem Cell
- A pre-clinical model of resistance to induction therapy in pediatric acute lymphoblastic leukemia
- (2014) A L Samuels et al. Blood Cancer Journal
- AML cells are differentially sensitive to chemotherapy treatment in a human xenograft model
- (2013) M. Wunderlich et al. BLOOD
- Therapeutic antagonists of microRNAs deplete leukemia-initiating cell activity
- (2013) Chinavenmeni S. Velu et al. JOURNAL OF CLINICAL INVESTIGATION
- Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel
- (2012) U. Creutzig et al. BLOOD
- Pharmacokinetic Modeling of an Induction Regimen for In Vivo Combined Testing of Novel Drugs against Pediatric Acute Lymphoblastic Leukemia Xenografts
- (2012) Barbara Szymanska et al. PLoS One
- AML xenograft efficiency is significantly improved in NOD/SCID-IL2RG mice constitutively expressing human SCF, GM-CSF and IL-3
- (2010) M Wunderlich et al. LEUKEMIA
- Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
- (2009) H. Dohner et al. BLOOD
- Comparison of Native E. coli and PEG Asparaginase Pharmacokinetics and Pharmacodynamics in Pediatric Acute Lymphoblastic Leukemia
- (2009) J C Panetta et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Microenvironment Determines Lineage Fate in a Human Model of MLL-AF9 Leukemia
- (2008) Junping Wei et al. CANCER CELL
- Non-obese diabetic-recombination activating gene-1 (NOD-Rag 1null) interleukin (IL)-2 receptor common gamma chain (IL 2 rγnull) null mice: a radioresistant model for human lymphohaematopoietic engraftment
- (2008) T. Pearson et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Human acute leukemia cells injected in NOD/LtSz-scid/IL-2Rγnull mice generate a faster and more efficient disease compared to other NOD/scid-related strains
- (2008) Alice Agliano et al. INTERNATIONAL JOURNAL OF CANCER
- Busulfan Produces Efficient Human Cell Engraftment in NOD/LtSz-Scid IL2RγNullMice
- (2008) Jun Hayakawa et al. STEM CELLS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now